Product
Estramustine
Aliases
estramustine phosphate sodium
Name
Emcyt
INN Name
estramustine phosphate sodium
FDA Approved
Yes
3 clinical trials
1 organization
1 indication
1 document
Indication
Prostate CancerClinical trial
Phase II Study of Weekly Paclitaxel by 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate CarcinomaStatus: , Estimated PCD: 2005-04-01
Clinical trial
A Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) Versus Paclitaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients With a Rising PSA After Hormonal Therapy for Prostate CancerStatus: , Estimated PCD: 2004-12-01
Clinical trial
A Randomized Phase II Trial of Mitoxantrone, Estramustine and Navelbine or 13-cis Retinoic Acid, Interferon and Paclitaxel in Patients With Metatstatic Hormone Refractory Prostate CancerStatus: , Estimated PCD: 2004-07-01
Document
DailyMed Label: EmcytOrganization
Pfizer Laboratories Div Pfizer Inc